Atecegatran (AR-H067637) is an orally active, competitive thrombin inhibitor with a Ki of 2–4 nM; it inhibits platelet activation and aggregation by blocking thrombin binding to fibrin and thrombomodulin; it exhibits potent anticoagulant effects in various plasma coagulation assays with IC50 values ranging from 93 to 220 nM; it can be used in research related to thrombotic disorders.